Cargando…
Repurposing Clinical Molecule Ebselen to Combat Drug Resistant Pathogens
Without a doubt, our current antimicrobials are losing the battle in the fight against newly-emerged multidrug-resistant pathogens. There is a pressing, unmet need for novel antimicrobials and novel approaches to develop them; however, it is becoming increasingly difficult and costly to develop new...
Autores principales: | Thangamani, Shankar, Younis, Waleed, Seleem, Mohamed N. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4519285/ https://www.ncbi.nlm.nih.gov/pubmed/26222252 http://dx.doi.org/10.1371/journal.pone.0133877 |
Ejemplares similares
-
Repurposing ebselen for treatment of multidrug-resistant staphylococcal infections
por: Thangamani, Shankar, et al.
Publicado: (2015) -
Repurposing celecoxib as a topical antimicrobial agent
por: Thangamani, Shankar, et al.
Publicado: (2015) -
Repurposing ebselen for decolonization of vancomycin-resistant enterococci (VRE)
por: AbdelKhalek, Ahmed, et al.
Publicado: (2018) -
Topical delivery of ebselen encapsulated in biopolymeric nanocapsules: drug repurposing enhanced antifungal activity
por: Jaromin, Anna, et al.
Publicado: (2018) -
Combating Intracellular Pathogens with Repurposed
Host-Targeted Drugs
por: Schor, Stanford, et al.
Publicado: (2018)